May is GBS and CIDP Awareness Month: Spreading Rare Disease Awareness
source: pixabay.com

May is GBS and CIDP Awareness Month: Spreading Rare Disease Awareness

The month of May is recognized as Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) awareness month, a time set aside to spread awareness about these rare conditions among…

Continue Reading May is GBS and CIDP Awareness Month: Spreading Rare Disease Awareness
Orphan Drug Designation Provided to a Treatment for Chronic Inflammatory Demyelinating Polyneuropathy
source: pixabay.com

Orphan Drug Designation Provided to a Treatment for Chronic Inflammatory Demyelinating Polyneuropathy

The FDA has just provided Orphan Drug Designation to Hizentra for the treatment of adults diagnosed with chronic inflammatory demyelinating polyneuropathy (CIPD). This is a maintenance therapy which works to…

Continue Reading Orphan Drug Designation Provided to a Treatment for Chronic Inflammatory Demyelinating Polyneuropathy

Webinar: CIDP Patient Speaker Program

  • Post author:
  • Post category:

Speakers: Elizabeth Thirtyacre Carla Duff, ANP To register for this webinar, click here. To read more about Webinar Wednesdays, click here.    Acknowledgment: This event post is sponsored by CSL Behring and is…

Continue Reading Webinar: CIDP Patient Speaker Program

Dallas, TX Live Event: CIDP Patient Speaker Program

  • Post author:
  • Post category:

Speakers: Carla Duff ARNP, CPNP-PC, MSN, CCRP, IgCN Patricia Skinner To register for this live event, click here.  For information on CIDP Webinar Wednesdays with this PW collaborator, click here. And…

Continue Reading Dallas, TX Live Event: CIDP Patient Speaker Program